Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | AGIOS PHARMACEUTICALS, INC. | Foster-Cheek Kaye I
(Director) |
S | Common stock | D | 4715 | $31.99 - $32.21 | $150,898 |
| 2024-03-05 | AGIOS PHARMACEUTICALS, INC. | Washburn Theodore...
(Principal Accounting Officer) |
S | Common stock | D | 1913 | $31.75 - $31.75 | $60,737 |
| 2024-03-05 | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia
(Chief Financial Officer) |
S | Common stock | D | 672 | $32.57 - $32.57 | $21,887 |
| 2024-03-01 | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia
(Chief Financial Officer) |
M | Common stock | A | 2000 | $0.00 - $0.00 | $0 |
| 2024-03-05 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
S | Common stock | D | 2642 | $32.57 - $32.57 | $86,049 |
| 2024-03-01 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
M | Common stock | A | 7834 | $0.00 - $0.00 | $0 |
| 2024-02-20 | AGIOS PHARMACEUTICALS, INC. | Washburn Theodore...
(Principal Accounting Officer) |
S | Common stock | D | 504 | $26.63 - $26.63 | $13,421 |
| 2024-02-14 | AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah
(Chief Medical Officer) |
S | Common stock | D | 642 | $25.14 - $25.14 | $16,139 |
| 2024-02-12 | AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah
(Chief Medical Officer) |
M | Common stock | A | 2162 | $0.00 - $0.00 | $0 |
| 2024-02-14 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
S | Common stock | D | 545 | $25.14 - $25.14 | $13,701 |
| 2024-02-12 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
M | Common stock | A | 1833 | $0.00 - $0.00 | $0 |
| 2024-02-14 | AGIOS PHARMACEUTICALS, INC. | Washburn Theodore...
(Principal Accounting Officer) |
S | Common stock | D | 273 | $25.14 - $25.14 | $6,863 |
| 2024-02-12 | AGIOS PHARMACEUTICALS, INC. | Washburn Theodore...
(Principal Accounting Officer) |
M | Common stock | A | 777 | $0.00 - $0.00 | $0 |
| 2024-01-24 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
S | Common stock | D | 1708 | $21.64 - $21.64 | $36,961 |
| 2024-01-20 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
M | Common stock | A | 5750 | $0.00 - $0.00 | $0 |
| 2024-01-24 | AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah
(Chief Medical Officer) |
S | Common stock | D | 1708 | $21.64 - $21.64 | $36,961 |
| 2024-01-20 | AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah
(Chief Medical Officer) |
M | Common stock | A | 5750 | $0.00 - $0.00 | $0 |
| 2024-01-24 | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia
(Chief Financial Officer) |
S | Common stock | D | 1886 | $21.64 - $21.64 | $40,813 |
| 2024-01-20 | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia
(Chief Financial Officer) |
M | Common stock | A | 5380 | $0.00 - $0.00 | $0 |
| 2024-01-24 | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A
(Director) |
S | Common stock | D | 10722 | $21.64 - $21.64 | $232,024 |
| 2024-01-20 | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A
(Director) |
M | Common stock | A | 23900 | $0.00 - $0.00 | $0 |
| 2024-01-24 | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta
(Chief Commercial Officer) |
S | Common stock | D | 1618 | $21.64 - $21.64 | $35,013 |
| 2024-01-20 | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta
(Chief Commercial Officer) |
M | Common stock | A | 5448 | $0.00 - $0.00 | $0 |
| 2024-01-09 | AGIOS PHARMACEUTICALS, INC. | Goff Brian
(Chief Executive Officer) |
S | Common stock | D | 12066 | $22.99 - $22.99 | $277,397 |
| 2024-01-05 | AGIOS PHARMACEUTICALS, INC. | Goff Brian
(Chief Executive Officer) |
M | Common stock | A | 25527 | $0.00 - $0.00 | $0 |
| 2024-01-09 | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A
(Director) |
S | Common stock | D | 8391 | $22.99 - $22.99 | $192,909 |
| 2024-01-05 | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A
(Director) |
M | Common stock | A | 17500 | $0.00 - $0.00 | $0 |
| 2024-01-09 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
S | Common stock | D | 1163 | $22.99 - $22.99 | $26,737 |
| 2024-01-05 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
M | Common stock | A | 3250 | $0.00 - $0.00 | $0 |
| 2024-01-05 | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta
(Chief Commercial Officer) |
S | Common stock | D | 2902 | $22.32 - $22.32 | $64,772 |
| 2024-01-03 | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta
(Chief Commercial Officer) |
M | Common stock | A | 8475 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |